Consistent with the immunofluorescence, NET-specific markers such as circulating extracellular DNA and myeloperoxidase were increased in plasma samples from COVID-19 patients (n = 43) over healthy control donors (n = 39) (Supplementary table 1 and Supplementary Fig. 1a+b). The gene discussed is MPO; the disease is COVID-19.